Abstract:Introduction: Evans syndrome (ES) is a rare autoimmune disorder characterized by the development of autoimmune hemolytic anemia (AIHA), immune thrombocytopenia (ITP), and/or immune neutropenia (AIN) without an identifiable cause. It is believed to involve immune system dysregulation, leading to the destruction of red blood cells, platelets, and neutrophils. Case Presentation: A 68-year-old male with a history of coronary artery disease, hypertension, diabetes, and atrial fibrillation presented with abdominal pain and diarrhea. Laboratory tests revealed a platelet count of 3k, suggesting ITP. Initial treatment with dexamethasone and platelet transfusion provided limited improvement. A bone marrow biopsy showed mildly hypercellular bone marrow with trilineage hematopoiesis. However, the patient's condition rapidly deteriorated, and he returned to the emergency department with severe symptoms, including headache, gum bleeding, and lower extremity petechiae. A CT scan revealed a large intraparenchymal hematoma with intraventricular hemorrhage, highlighting the risk of life-threatening bleeding in ES patients. Discussion: The patient was managed with platelet transfusions, high-dose steroids, and intravenous immunoglobulin (IVIG), which provided temporary relief but failed to maintain stable platelet levels. Further investigations revealed a positive antinuclear antibody (ANA), suggesting an underlying rheumatological condition and confirming the diagnosis of secondary ES. This finding necessitated the exploration of treatment options. Of interest is Romiplostim (Promacta), a thrombopoietin receptor agonist, which has shown promise in increasing platelet counts and reducing bleeding episodes in refractory ITP. Considering the positive ANA and the suspected rheumatological etiology, Romiplostim may serve as a viable long-term treatment option to stabilize platelet levels and mitigate bleeding risks in this case. Conclusion: This case highlights the complexity of Evans syndrome and emphasizes the need to promptly recognize and manage life-threatening bleeding complications, particularly in older patients. The presence of a positive ANA suggests an underlying rheumatological condition, necessitating comprehensive evaluation, and tailored therapeutic approaches. Although further research is needed to understand the pathogenesis and optimal management strategies for ES, Romiplostim holds promise as a potential treatment for patients with secondary ES who are unresponsive to conventional therapies. Citation Format: Kiersten R. Patterson, Aliya M. Khan, Raj Patel. Intracerebral and intraventricular hemorrhage due to severe thrombocytopenia: A rare case of Evans syndrome [abstract]. In: Proceedings of the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2023 Sep 29-Oct 2;Orlando, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(12 Suppl) nr B030.

Splenic Artery Embolization in a Patient With Intracranial Hemorrhage Due to Refractory Persistent Immune Thrombocytopenia

Splenic Artery Embolization as a Treatment Option for Chronic Pancytopenia Secondary to Hypersplenism

Splenic Artery Embolization and Splenectomy for Spontaneous Rupture of Splenic Hemangioma and Its Imaging Features

Partial Splenic Artery Embolization for Idiopathic Warm Autoimmune Hemolytic Anemia Refractory to Medical Therapy

Splenic embolization in treatment of portal vein occlusion deferring liver transplantation

[Partial splenic embolization as a preoperative treatment for refractory idiopathic thrombocytopenic purpura]

Improving cytopenia with splenic artery embolization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab

How complicated can be a case with immune thrombocytopenic purpura?: postsplenectomy arterial thrombosis

Superselective Transcatheter Renal Artery Embolization for the Treatment of Hemorrhage from Non-Iatrogenic Blunt Renal Trauma: Report of 16 Clinical Cases

Abstract B030: Intracerebral and intraventricular hemorrhage due to severe thrombocytopenia: A rare case of Evans syndrome

Acute Pancreatitis Associated Left-Sided Portal Hypertension with Severe Gastrointestinal Bleeding Treated by Transcatheter Splenic Artery Embolization: a Case Report and Literature Review

Splenic Artery Embolization in Patients After Orthotopic Liver Transplant.

Rescue splenic artery embolization in an adult patient of sickle cell disease presented with acute splenic sequestration crisis

Plasmapheresis combined with rituximab treatment of a case of thrombotic thrombocytopenic purpura with Sjögren syndrome and renal impairment: A case report

Primary splenic angiosarcoma: a rare case of embolization as a bridge to splenectomy

Total Embolization of the Main Splenic Artery As a Supplemental Treatment Modality for Hypersplenism

Splenic Artery Embolization: Endovascular and Percutaneous Trans-splenic Approach

Splenic Arterial Embolization for Trauma and Beyond: A Case Series

Splenic artery embolization in the treatment of blunt splenic injury: single level 1 trauma center experience

The use of splenic embolization in immune thrombocytopenia: A systematic review and meta‐analysis

Selective embolization with autologous fat to treat massive bleeding secondary to percutaneous renal biopsy